Download as PDF, PPTX
Uploaded byInsights10
Global Clinical Trial Patient Recruitment Services Market Analysis Sample Report
The document provides a comprehensive analysis of the global clinical trial patient recruitment services market, including insights on market size, segmentation, and key players from 2022 to 2030. It details market dynamics, growth factors, and challenges while presenting a forecast for future developments. The report emphasizes the significance of efficient patient recruitment in clinical trials, highlighting the associated costs and impacts on study timelines.
Healthcareโฆ
More Related Content
Similar to Global Clinical Trial Patient Recruitment Services Market Analysis Sample Report
![India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...](https://cdn.slidesharecdn.com/ss_thumbnails/indiaclinicaltrialsmarket-240529104226-cbac2dd0-thumbnail.jpg?width=640&height=640&fit=bounds)
Global Clinical Trial Patient Recruitment Services Market Analysis Sample Report
- 1. Global Clinical Trial PatientRecruitment Services A sample report on www.insights10.com Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2022 โ 2030F)
- 2. This report presentsa strategic analysis of the Global Clinical Trial Patient Recruitment Services Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Global Clinical Trial Patient Recruitment Services Market, and offers unmatched value, accuracy, and expert insights
- 3. 3 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Report Coverage Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Quantitative Units Revenue in GlobalD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology
- 4. 4 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Table of Content CONTENT PG. NO. 1. Global Clinical Trial Patient Recruitment Services Market Overview 12-25 1.1. Overview 1.2. Global Overview 1.3. Economic Overview: Global 1.4. Clinical Trial Patient Recruitment Services Market in Global 1.5. Healthcare Scenario in Global 1.6. Health Insurance Coverage: Global 1.7. Budget of the Government for Public Insurance 1.8. Mergers and Acquisitions 2. Market Size and Forecasting 26-30 2.1 Market size and forecasts (Excel and Methodology)
- 5. 5 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. Market Segment 1 2.2.2. Market Segment 2 2.2.3. Market Segment 3 3. Market Dynamics 31-34 3.1. Market Growth Drivers 3.1.1. Global Clinical Trial Patient Recruitment Services Market Driver 1 3.1.2. Global Clinical Trial Patient Recruitment Services Market Driver 2 3.1.3. Global Clinical Trial Patient Recruitment Services Market Driver 3 3.2. Market Restraints 3.2.1. Global Clinical Trial Patient Recruitment Services Market Restraint 1 3.2.2. Global Clinical Trial Patient Recruitment Services Market Restraint 2
- 6. 6 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Table of Content CONTENT PG. NO. 3.2.3. Global Clinical Trial Patient Recruitment Services Market Restraint 3 4. Competitive Landscape 35-45 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. IQVIA 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 4.2.2. AutoCruitment 4.2.2.1. Overview
- 7. 7 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Table of Content CONTENT PG. NO. 4.2.2.2. Product Applications & Services 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. Antidote 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 4.2.4. BBK Worldwide 4.2.4.1. Overview
- 8. 8 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Table of Content CONTENT PG. NO. 4.2.4.2. Product Applications & Services 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. CSSi 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 4.2.6. Elligo Health Research 4.2.6.1. Overview
- 9. 9 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Table of Content CONTENT PG. NO. 4.2.6.2. Product Applications & Services 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. Praxis 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 4.2.8. Science37 4.2.8.1. Overview
- 10. 10 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Table of Content CONTENT PG. NO. 4.2.8.2. Product Applications & Services 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. Trialspark 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 4.2.10. TrialX 4.2.10.1. Overview
- 11. 11 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Table of Content CONTENT PG. NO. 4.2.10.2. Product Applications & Services 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 5. Reimbursement Scenario 46-53 5.1. Reimbursement Regulation 5.2. Reimbursement Process for Diagnosis 5.3. Reimbursement Process for Treatment 5.4 Reimbursement Process โ Medicare 5.5 Reimbursement Process - Medicaid 6. Methodology & Scope 54
- 12. Global Clinical TrialPatient Recruitment Services Market Analysis 1. Global Clinical Trial Patient Recruitment Services Market Overview
- 13. 13 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.1 Statistics at a Glance: The Scenario of Global Clinical Trial Patient Recruitment Services Market in the World Scope of Global Clinical Trial Patient Recruitment Services Market โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest $779.5 Mn In 2022, the market for clinical trial patient recruiting services had been predicted to be worth $779.5 Mn $1.3 Mn Budgets for clinical trial funders have significantly increased, as have the costs associated with delays. If a clinical trial is delayed because of problems with recruitment, they could lose up to $1.3 Mn every day 32% The most expensive part of clinical trials is patient recruitment, which accounts for 32% of overall costs 50.4% With the greatest revenue share of 50.4% in 2021, North America dominated the world market
- 14. 14 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.1 Statistics at a Glance: The Burden of Global Clinical Trial Patient Recruitment Services Market in the World (continued) North America ~ Market Size of $xx Bn Europe ~Revenue to reach $xx Bn by 2027 Asia -Fastest CAGR Africa ~Market Size of $xx Illustrative
- 15. 15 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.2 Global Overview 7.97 Bn Is the Global population, in 2023 30 Is the median age in Global, in 2022 94.69Tn Is the Gross Domestic Product (GDP) in Global in 2021 $10 Tn Public and private healthcare spending is anticipated to reach over $10 trillion globally by 2024. โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
- 16. 16 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.3 Economic Overview: Global XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population of Global, (2020-2030) XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F GDP of Global, (2020-2030) Population Split (2023) 55-64 0-14 15-24 25-54 65+ Male 49% Female 51% By Age Group By Gender โช In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative
- 17. 17 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.4 Global Healthcare Services xx xx xx xx xx xx xx xx xx 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Global Healthcare Services Market Forecast, 2022-2030 (in $Bn) โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In this section you will get an understanding of the overall Clinical Trial Patient Recruitment Services market in Global, which includes the market size, current trends and other details related to the topic โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative
- 18. 18 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.5 Healthcare Scenario in World Clinical Trials Development Process: The process of developing a Clinical Trials is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the Clinical Trials development process: o Preclinical Research: Researchers identify potential drug candidates and test them in the lab o Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans o Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating Clinical Trials o Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness o Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for Globale in the Global market Fast Track โช Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serioGlobal conditions and fill an unmet medical need Breakthrough Therapy โช A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Accelerated Approval โช These regulations allowed drugs for serioGlobal conditions that filled an unmet medical need to be approved based on a surrogate endpoint Priority Review โช A Priority Review designation means FDAโs goal is to take action on an application within 6 months FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Illustrative
- 19. 19 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.6 Healthcare Scenario: Patient Journey Presentation Diagnosis Treatment Follow up A sGlobalpected diagnosis is Globalually made, based on physical examination and detailed patient and family history Prenatal screening/ Neonatal screening Initial Diagnosis Complete blood count (evaluate number & quality of RBCs, Hb & WBCs) Imaging (confirm bone related changes or respiratory problems) Bacterial cultures of blood, sputum, urine, stool (detect any infection) Genetic testing (detect the type of SCD) Confirmatory Diagnosis Prevention and management of crisis: โข For VOC and Splenic Sequestration: HU, Endari, Adakveo, Oxbryta โข For infections: Antibiotics, Vaccines Prevention and management of complications: โข Stroke: Chronic transfGlobalions, HU โข Long term follow-up is required for patients with SCD โข Annual assessment: CBC and reticulocyte count, iron statGlobal, liver and renal function tests, urinalysis, LDH, vitamin D level and neurocognitive assessment โข ESOD (End Stage Organ Damage) evaluation starting from age 7 โข Yearly Transcranial Doppler test to determine risk of stroke Stakeholders PCP, paediatrician, neonatologist, haematologist and genetic counsellor PCP, pediatrician, medical geneticist, hematologist, gynecologist and pathologist PCP, pediatrician, medical geneticist, cardiologist, hematologist, endocrinologist, psychologist and psychiatrist PCP, pediatrician, neonatologist, endocrinologist, cardiologist, hematologist, orthopedist, psychologist and psychiatrist Depending on the organ complications, the treatment involves different specialists at different times Illustrative
- 20. 20 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.7 Health Insurance Coverage: Global 1.0 18.9 18.4 35.7 2.5 3.5 10.2 54.3 66.0 91.7 8.3 VA and CHAMPVA Medicaid Medicare Any public plan TRICARE Marketplace Direct-purchase Employment-based Any private plan With health insurance Uninsured โช In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year โช More people had private health insurance (66%) than public coverage (35.7%) โช Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) Coverage Type 2020 2021 Change % Total 327,521 328,074 Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 โ0.6 Employment-based 178,737 178,285 โ0.2 Direct-purchase 33,869 33,555 โ0.1 Marketplace coverage 10,924 11,389 0.1 TRICARE 9,165 8,299 โ0.3 Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 Medicaid 58,778 61,940 0.9 VA and CHAMPVA 2,967 3,151 0.1 Uninsured 28,291 27,187 โ0.4 % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Illustrative
- 21. 21 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.8 Budget of Global Government for Public Insurance Proposed Budget By Category Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 In Billions Of Dollars Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 As % Of GDP Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% โช National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) โช Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE โช Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE โช Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE โช Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE โช Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE โช Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 โช Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 โช Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 โช Largest shares of total health spending were sponsored by the federal government (34%) and the hoGlobaleholds (27%). The private bGlobaliness share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% Illustrative
- 22. 22 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.9 Mergers and Acquisitions $6.0 $7.7 $10.5 $16.7 $6.8 $11.7 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 82 112 107 107 89 110 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend Buyer Composition: Strategic Vs Financial (2020) 59% 41% 41% 59% 58% 42% 61% 39% $0- $25 $25-$50 $50-$100 $100+ Strategic Buyers Financial Buyers Buyer Type by Deal Size ($Mn) Illustrative
- 23. 23 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.9 Mergers and Acquisitions (continued) Company Name Type Amount / Duration Year Key Pointers Oracle acquisition of Cerner Acquisition $28.3 Bn June, 2022 โช Oracleโs acquisition of Cerner is big techโs latest foray into the healthcare system, promising better outcomes โช Oracle acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 Bn in equity value โช Cerner is a leading provider of digital information systems Globaled within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities GSK acquisition of BELLGlobal Health Acquisition $2 Bn April 2023 โช GSK has acquire BELLGlobal for Global$14.75 per share of common stock in cash representing an approximate total equity value of Global$2.0 billion โช BELLGlobal is a late-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough โช Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough Latest Deals In Global Illustrative
- 24. 24 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 1.9 Mergers and Acquisitions(continued) Company Name Type Amount / Duration Year Key Pointers Merger March 2023 Merger Jan 2023 Latest Deals In Global Illustrative
- 25. Global Clinical TrialPatient Recruitment Services Market Analysis 2. Market Size and Forecasting
- 26. 26 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 2.1 Market size and forecasts (Excel and Methodology) XX XX 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Global Clinical Trials Patient Recruitment Services Market Forecast, 2022-2030 (in $Bn) โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Click on the icon to know the methodology and assumption 2023 2024 2025 2026 2027 2028 2029 2030 Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Global Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 % of Global Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Global Market Size (Bn $) 61 74 84 87 91 95 99 106 Illustrative
- 27. 27 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 2.2 Snapshot of Global Clinical Trial Patient Recruitment Services Market Segmentation โช In this section you will get an understanding of the segmentations which will cover the Global Clinical Trial Patient Recruitment Services Market โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Service Type Patient Recruitment & Registry Services Patient Retention Services Trial Phases Phase I Phase II Phase III Phase IV Therapeutics Areas Respiratory Diseases Pain and Anaesthesia Oncology Central Nervous System Cardiovascular Age Group Child (Birth-17 Years) Adult (18 - 64 Years) Older Adults (65 Years+) Region APAC North America Europe Africa Middle East
- 28. 28 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Global Clinical Trials Patient Recruitment Services Market Share, By Service Type (2022) Patient Retention Services Patient Recruitment & Registry Services โช Patient Retention services market in Global is a significant component of the overall Clinical Trials treatment market โช It has the maximum market share in Global Clinical Trials market with approximately xx% โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest 2.2.1 Market Segmentation: By Service Type
- 29. 29 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Global Clinical Trials Patient Recruitment Services Market Share, By Trial Phases (2022) Phase I Phase II Phase III Phase IV 2.2.2 Market Segmentation: By Trial Phases โช Phase I market in Global is a significant component of the overall Clinical Trials market โช It has the maximum market share in Global Clinical Trials market with approximately XX% โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
- 30. 30 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Global Clinical Trials Patient Recruitment Services Market Share, Therapeutics Areas (2022) Respiratory Diseases Pain and Anaesthesia Oncology Central Nervous System Cardiovascular 2.2.3 Market Segmentation: By Therapeutics Areas โช Respiratory Diseases Market have the maximum market share in Global Clinical Trials market with approximately xx% โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
- 31. 31 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Global Clinical Trials Patient Recruitment Services Market Share, By Age Group (2022) Child Birth Adult Older Adult 2.2.4 Market Segmentation: By Age Group โช Child Birth market in Global is a significant component of the overall Clinical Trials market โช It has the maximum market share in Global Clinical Trials market with approximately XX% โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
- 32. 32 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential Global Clinical Trials Patient Recruitment Services Market Share, By Region (2022) APAC North America Europe Africa Middle East 2.2.5 Market Segmentation: By Region โช APAC Market have the maximum market share in Global Clinical Trials market with approximately xx% โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
- 33. Global Clinical TrialPatient Recruitment Services Market Analysis 3. Market Dynamics
- 34. 34 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 3.1 Market growth drivers โช The growing need to develop new treatments for diseases and the rise in the number of clinical trials being conducted globally are driving the demand for patient recruitment services. โช This is driving the demand for Clinical Trials and creating opportunities for growth in the Clinical Trials market โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest 2010 2022 2030 3.1.1 More than 30% of clinical trials were registered in the US by February 2023, and it is projected that as a result of the considerable growth in clinical trials worldwide, which will ultimately lead to market expansion Clinical Trials in Global
- 35. 35 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 3.1 Market growth drivers (continued) Top countries that are leveraging technology in their fight against Clinical Trials United States Japan Germany South Korea China United Kingdom France Canada Australia Israel Switzerland Singapore Sweden Netherlands Italy Spain Belgium Denmark Austria Norway 3.1.2 The cancer category had the biggest revenue share in 2021, with about 34.68%. The demand for drugs has accelerated due to the rise in cancer prevalence. Thus, this feature raises the need for clinical trials and, as a result, helps the market grow โช Global has a long history of investing in Clinical Trials research โช .The demand for medications and therapies to treat and manage the disease has increased as cancer is becoming more common. โช As a result of efforts by researchers and pharmaceutical corporations to create novel and efficient therapies, the need for clinical trials has increased. โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative
- 36. 36 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 3.2 Market restraints 3.2.1 Insufficient enrollment causes the termination of 34.68% of clinical trials before testing ever starts โช Inadequate enrolment can cause delays in the trial's execution or, in some situations, the trial's discontinuation if an insufficient number of participants is enlisted. โช Enrollment challenges may be caused by elements like stringent qualifying requirements, low participant awareness, geographical restrictions, and other practical problems. 3.2.2 84.68% of Clinical Trials fail to enroll adequate patients because of low patient awareness and participation โช Recruitment attempts may be hampered by patients' lack of knowledge about clinical trials and their potential advantages โช Many people can be unaware of the chance to take part in clinical trials or they might have preconceived notions about the procedure and hazards involved. โช Finding qualified and enthusiastic participants could become challenging as a result. 3.2.3 Demand for Clinical Trials care is expected to increase by 62.58% by 2035, while the supply is only expected to increase by 29.68% โช There is a shortage of Clinical Trials in Global โช which can limit access to Clinical Trials โช and create barriers to growth in the Clinical Trials patient recruitment services market Our analysis will thoroughly investigate the key restraints that may significantly impact bGlobaliness operations and growth.
- 37. Global Clinical TrialPatient Recruitment Services Market Analysis 4. Competitive Landscape
- 38. 38 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 4.1 Major Market Share XX Other โช Global Clinical Trials market is a highly competitive space, with many companies developing and marketing Clinical Trials treatments โช Some of the top companies in Global Clinical Trials market based on revenue and market share include โช IQVIA is a Swiss multinational healthcare company that develops and markets Clinical Trials treatments, including targeted therapies and immunotherapies โช In 2020, IQVIA's oncology sales were approximately $24 Bn, making it one of the largest players in Global Clinical Trials market Revenue of Major players in Global Clinical Trials Patient Recruitment Services Market ($ Mn) Illustrative
- 39. 39 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 4.2 Key Company Profile โช Here is the list of top 10 companies which will cover in the final report โช Each company will have slides for o Overview o Key details o Offerings o Name of products o Recent activities/ Press Coverage o Distribution and Vendor Partners o Mergers, Acquisitions and Collaboration o Financials โช If there are specific companies that you would like to be included in the report, please let Global know via email โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report 1 IQVIA 3 Antidote 5 CSSi 7 Praxis 9 TrialSpark 2 AutoCruitment 4 BBK Worldwide 6 Elligo Health Research 8 Science37 TrialX 10 Key Note:
- 40. 40 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 4.2.1 IQVIA Founded in: 1982 HQ: North Carolina, United States Type: Public Revenue: $14,410 Mn Website: www.iqvia.com โช The American multinational corporation IQVIA provides services to the combined fields of clinical trials and health information technology. โช IQVIA Direct-to-Patient recruiting helps remove barriers that increase time, cost, โช and uncertainty in recruiting efforts by utilizing machine learning and unprecedented patient data and insight. Solutions offered by IQVIA โข Safety Pharmacovigilance โข Medical Information โข Commercial Compliance โข Clinical Trials โข Patient Support Recent Activity / Press Coverage IQVIA and (RED) Declare a Groundbreaking Partnership to Support the Strengthening of the Laboratory System Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science According to the IQVIA Institute, the use of medicines in the United States grew in 2022 while patient out-of-pocket expenses remained low.
- 41. 41 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 4.2.1 IQVIA (continued) Major Distribution Partners Major Vendor Partners Partnerships Ecosystem One of the largest pharmaceutical distributors in the United States, McKesson has been a long-standing distribution partner for IQVIA Cardinal Health is a Fortune 500 healthcare services company that provides pharmaceutical distribution services to IQVIA It is one of the largest drugstore chains in the United States and Europe, and its extensive network of retail locations and distribution centers make it an important distribution partner for IQVIA A leading healthcare services provider in Asia, Zuellig Pharma is a distribution partner for IQVIA in several Asian countries One of the largest pharmaceutical wholesalers in Europe, PHOENIX Group distributes IQVIA's products in several European countries IQVIA has been working with SAP, a leading software company, to develop digital solutions for its healthcare products A leading Swiss biotechnology company, Lonza provides IQVIA with contract manufacturing services for the production of its biologics and pharmaceuticals IQVIA has a strategic partnership with Microsoft to leverage its cloud computing and AI technologies in the development of new healthcare products Thermo Fisher Scientific is a leading provider of analytical instruments, reagents, and laboratory services GE Healthcare provides IQVIA with advanced medical imaging and diagnostics technologies, including CT scanners and MRI machines Illustrative
- 42. 42 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 4.2.1 IQVIA (continued) Company Name Type Amount / Duration Year Key Pointers Lilly Collaboration - March, 2023 โช IQVIA and Lilly will collaborate on the development of IQVIA Diagnosticsโ Elecsys Amyloid Plasma Panel โช Elecsys Amyloid Plasma Panel has demonstrated clinical performance and is currently undergoing additional investigation to ensure clinical validation โช Once approved, could help healthcare professionals to streamline the journey to diagnosis for more patients GenMark Diagnostics Merger $1.8 Bn March 2021 โช IQVIA to acquire GenMark Diagnostics for Global$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 โช GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample โช GenMarkโs ePlex platform delivers rapid and actionable results so clinicians can determine the caGlobale of infection and the most effective treatment, potentially saving lives and alleviating the healthcare burden Latest Deals - Mergers and Acquisitions Illustrative
- 43. 43 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 63.3 70.3 70.9 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F 4.2.1 IQVIA (continued) Revenues ($Bn), 2020-2030 โช According to IQVIA's 2020 financial report, the company had sales of CHF 58.3 Bn (Swiss Francs) in 2020 โช This is equivalent to approximately $63.3 Bn, based on exchange rates at the end of 2020 โช Company's Pharmaceuticals Division generated sales of CHF 49.9 Bn in 2020, while the Diagnostics Division generated sales of CHF 8.4 Bn โช Revenue generated by IQVIA in 2020 reflects the company's continued growth and success in the healthcare indGlobaltry โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Breakdown of Net Revenue by Segment, 2022 1 2 3 4 Illustrative
- 44. 44 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 4.2.2 Company 2 Founded in: HQ: Type: Revenue: Website: Solutions offered by Company Drugs Indications Drugs for Clinical Trials Recent Activity / Press Coverage Illustrative
- 45. 45 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 4.2.2 Company 2 (continued) Major Distribution Partners Major Vendor Partners Partnerships Ecosystem Illustrative
- 46. 46 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 4.2.2 Company 2 (continued) Company Name Type Amount / Duration Year Key Pointers Latest Deals - Mergers and Acquisitions Illustrative
- 47. 47 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential xx xx xx 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 โช Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report โช In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability โช In order to obtain access to all of the information that you are seeking, you will need to purchase the final report โช Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Breakdown of Net Revenue by Segment, 2022 1 2 3 4 Illustrative
- 48. Global Clinical TrialPatient Recruitment Services Market Analysis 5. Reimbursement Scenario
- 49. 49 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 5.1 Reimbursement Regulation The reimbursement scenario in the Global Clinical Trials market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: โช Medicare: o Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions o Medicare covers many Clinical Trials treatments, including chemotherapy, radiation therapy, and some immunotherapies o However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization โช Medicaid: o Medicaid is a joint federal-state program that provides health insurance for people with low incomes o Medicaid coverage for Clinical Trials treatments can vary by state, and may be subject to limits on the amount and type of treatment covered โช Private Insurance: o Private insurance coverage for Clinical Trials treatments can also vary widely depending on the insurer and the specific policy o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Americans Medicare 17% Medicaid and CHIP 21% Employer-Sponsored 49% Other Private 3% Other Public 1% Uninsured 9% Health Insurance Coverage, 2022 Illustrative
- 50. 50 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 5.1 Reimbursement Regulation (continued) โช Affordable Care Act: o Affordable Care Act (ACA) includes provisions to help improve access to Clinical Trials treatments by requiring insurers to cover certain preventive services, including Clinical Trials screenings, without co-pays or deductibles o It also includes protections for people with pre-existing conditions, such as Clinical Trials โช Reimbursement for New Treatments: o Reimbursement for new Clinical Trials treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage o This can create challenges for companies developing and marketing new treatments โช Value-Based Care: o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focGlobaling on the value of treatments rather than simply the volume of treatments o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative
- 51. 51 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 5.1 Reimbursement Regulation (continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) Reimbursement Market Trends ๏ก Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid ๏ก Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities ๏ก Medicaid is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources โช Shift towards value-based care has been a significant trend in the Global healthcare system, with payers and providers increasingly focGlobaled on improving patient outcomes and reducing costs โช This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care 38.9% 37.1% 35.6% 32.5% 31.5% 44.0% 46.0% 47.7% 51.0% 51.8% 2017 2018 2019 2020 2021 2022 2023 Government Expenditure Private Health Insurance Out of Pocket Other NA NA 100% 100% 100% 100% 100% xx xx xx xx xx 2012 2013 2014 2015 2016 Public Healthcare Coverage Private Coverage 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Illustrative
- 52. 52 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 5.2 Reimbursement Process The reimbursement process in the Global healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: โช Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient โช Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided โช Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud โช Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule โช Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative
- 53. 53 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 5.3 Reimbursement Process The reimbursement process in the Global healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: โช Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient โช Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided โช Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud โช Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule FDA Private Payers Public Payers Health Technology Assessment Payment Coverage Coding Coding depends on availability code while coverage and payment process decisions are made through an HTA. Market Authorization 1 3 2 Illustrative
- 54. 54 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 5.4 Reimbursement Process - Medicare Medicare Population Covered โช 100% population is covered under this scheme โช Citizenโs contribute to this scheme which then earns an interest. There is Basic Healthcare Sum (BHS) cap which limits the maximum contribution to an individuals Medicare account Provider Restrictions/ Selection Services can be claimed from Medicare-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community center and over 100 surgery centers, dialysis centers, colonoscopy centers and screening centers) Services Covered โช Medicines under SDL and MAF PlGlobal can be bought from the money saved in this account โช Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ transplant โช Money from this account can be Globaled to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits โช Patients above 65 years of age can claim under Flexi-Medicare and further reduce their out-of-pocket expenses by Globaling up to $200 per patient per year from their Medicare account โช Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicare account; Drugs Globaled for cosmetic purposes such as slimming pills and hair loss pills cannot be claimed from this account Level of Coverage/ Assurance โช Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicare up to $500 per account per year, however a cash copayment of 15% is applicable โช Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures โช Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures โช Outpatient scans/ diagnostics for Clinical Trials up to $600 per year per patient, and up to $300 for other medical conditions โช Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month per patient โช Renal dialysis up to $450 per patient per month โช Other treatments are also approved with varioGlobal sub-limits for withdrawal Mechanism of Coverage โช DRG with Activity Based Funding for public providers โช Block funding with DRG for providers not covered under ABF Financial Feasibility โช The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account Illustrative
- 55. 55 A Sample Reporton Global Clinical Trial Patient Recruitment Services Market Analysis I Confidential 5.5 Reimbursement Process - Medicaid Medicaid Population Covered โช 38% population is covered under this scheme โช Medicare covers individuals who are aged 65 and older, as well as those with certain disabilities or end-stage renal disease Provider Restrictions/ Selection Services can be claimed from Medicaid-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community center and over 100 surgery centers, dialysis centers, colonoscopy centers and screening centers) Services Covered โช Medicines under SDL and MAF PlGlobal can be bought from the money saved in this account โช Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ transplant โช Money from this account can be Globaled to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits โช Patients above 65 years of age can claim under Flexi-Medicaid and further reduce their out-of-pocket expenses by Globaling up to $200 per patient per year from their Medicaid account โช Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicaid account; Drugs Globaled for cosmetic purposes such as slimming pills and hair loss pills cannot be claimed from this account Level of Coverage/ Assurance โช Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicaid up to $500 per account per year, however a cash copayment of 15% is applicable โช Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures โช Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures โช Outpatient scans/ diagnostics for Clinical Trials up to $600 per year per patient, and up to $300 for other medical conditions โช Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month per patient โช Renal dialysis up to $450 per patient per month โช Other treatments are also approved with varioGlobal sub-limits for withdrawal Mechanism of Coverage โช DRG with Activity Based Funding for public providers โช Block funding with DRG for providers not covered under ABF Financial Feasibility โช The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account Illustrative
- 56. Global Clinical TrialPatient Recruitment Services Market Analysis 6. Methodology & Scope
- 57. Research Methodology โช Insights10โs research methodology delves deeper into the market, covering the macro and micro aspects of the indGlobaltry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future indGlobaltry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions โช We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources โช For forecasting, the following parameters are considered: โ Market drivers and restraints along with their current and expected impacts โ Technological scenario and expected developments โ End Globale indGlobaltry trends and dynamics โ Trends in the consumer behavior โ Regulatory scenario and expected developments โ Current capacity and expected capacity additions up to 2030 โช We assign weights to these parameters and quantify their market impacts Globaling the weighted average analysis to derive the expected market growth rate โช We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time- sensitive, reflecting the most recent value and volume of the market across regions โช All our estimates and forecasts are verified through exhaGlobaltive primary research with the Key IndGlobaltry Participants (KIPs) โช Currency Globaled in the report is the Global dollar (GlobalD), with the market size indicated in GlobalD million/billion (Mn/Bn) Illustrative
- 58. Analysis Methodology Our AnalysisMethodology involves three critical stages: Market Trends Market Sizing & Analysis Data Triangulation & Validation Analysis & Interpretation Insights Presentation & Reporting Market Data Analysis & Statistical Model Interpretation & Presentation Secondary Research Proprietary Database Data Collection Primary Research Illustrative
- 59. Data Triangulation &Data Validation Bottom Up Approach Summarization of revenue generated from companies to arrive at total market size Revenue generated by products & services offered by companies Validation from Primary Interview Final Market Size Top Down Approach Final Market size break up to rest of segmentation Arriving at market size of each segment Validation from Primary Interview Final Summary Illustrative
- 60. Key Benefits forStakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the indGlobaltry outlook, considering the qualitative and quantitative indGlobaltry variables Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the indGlobaltry from 2022 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities Extensive analysis of the key segments of the indGlobaltry helps understand the applications and technologies Globaled globally Our rigoroGlobal data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the indGlobaltry space, supply chain, price fluctuations, competitive landscape, and other vital factors
- 61. 2022 2023- 2030 Report Attribute Quantitative Units ReportCoverage CGlobaltomized Report Pricing and purchase options Revenue in GlobalD Million/Billion (Mn/Bn) Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Company Profiles, Competitive Landscape, Regulatory Landscape, Future Opportunities Report CGlobaltomization (3 to 5 working days) with purchase. We will provide you with data that is currently not a part of our scope as a part of cGlobaltomization Avail cGlobaltomized purchase options to meet your exact research needs Details Time Frame Base Year for Estimation Forecast Period
- 62.
- 63. Insights10 is ahealthcare focGlobaled market research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for bGlobalinesses www.insights10.com Lifesciences Market Research Reports you can trGlobalt
- 64. www.insights10.com A large databaseof over 30,000 syndicated market research reports in Clinical Trial Patient Recruitment Services and healthcare sector at global, regional as well as country level. We also provide cGlobaltomized research reports tailor made to suit your needs Get actionable insights to take informed bGlobaliness decisions
- 65. Our qualitative, acute,and result-oriented market research reports provide a comprehensive understanding of the bGlobaliness scenario and the latest trends related to the life sciences market Elevate your bGlobaliness plans with in-depth market analysis and indGlobaltry intelligence www.insights10.com
- 66. Whether you arelooking to expand into new areas, develop new products, or take advantage of new opportunities we have reports to help you accelerate and improve your plans by identifying unique growth prospects. Gain a competitive edge with Insights10's cGlobaltomized healthcare research solutions www.insights10.com
- 67. Healthcare Services Clinical Trials OTC & Nutraceuticals Clinical TrialPatient Recruitment Services (Diseases & Drugs) Digital Health Medical Devices across varioGlobal categories Market Research Reports
- 68. FEATURED REPORTS FREESAMPLE REPORTS TRENDING TOPICS
- 69. 1200+ Reports Published Annually 30000+ Life science Market Research Reports 22000+ Country Specific Reports 2000+ Rare& orphan Disease Reports What makes Global different?
- 70. Market Overview Growth Drivers& Growth Restraints Market Segmentation Market Share Factors Driving Future Growth Reimbursement Scenario Policy & Regulatory Landscape Key Company Profiles Epidemiology & Disease type Competitive Landscape insights on which our reports are based 1 2 3 4 5 6 10 9 8 7 Table of Contents
- 71.
- 72. Research Projects Done Overthe years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences. Our team has conducted market research across 62+ global markets in America, Europe, Middle East, Africa and Asia Pacific regions
- 73. Our Research Process 0103 02 04 05 Identification of Data Collection of Data Market Dynamics Collaboration of Data Verification & Analysis
- 74. Statistical Databases Data Sources We haveaccess to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. Company Websites/Annual Reports Trade Publications Online Databases Published Research Reports Whitepapers Press Releases of Key Market Players
- 75. What kind ofdata is presented in our reports? Our reports present data, which is: The report is prepared Globaling a proven methodology and insightful research Reliable The data is prepared by a team of highly qualified & experienced research analysts & vetted by our local associates Expert-verified Allowing you to confidently make smarter bGlobaliness and strategic decisions Real Covers everything you would need to know about the market including market size, competitive analysis & much more Comprehensive You do not have to be a market expert to understand what really is happening on the market and how it works Easy to read
- 76.
- 77. โThe bGlobaliness decision-makingprocess is no longer as straightforward as it Globaled to be. It requires insights generated at the right time, based on reliable data interpreted in a nuanced manner for each market. We at Insights10 are building the future of market research and are committed to providing our clients with the right intelligence and insights to make bGlobaliness decisions quickly and efficiently. Insighs10 is a unique platform that combines deep domain expertise, nuanced data at a country and functional area level, and years of experience working with some of the best organizations in the world, generating insights that provides substantial competitive advantage.โ Dr. Purav Gandhi Founder & CEO
- 78. Purav is aphysician and an entrepreneur with 12+ years of experience in Healthcare & Life Sciences indGlobaltry spanning across strategy, market access, health informatics and RWE, digital health, analytics and data science. Purav studied medicine from Gujarat University and also completed his MBA from IIM-Kozhikode. Purav started his career with Deloitte working on strategy consulting engagements and also co-founded ConvergeHealth by Deloitte. Anish has 15+ years of experience in management consulting in the Life Sciences sector, and has worked with diverse multinational firms in the Global, India, Middle East and APAC regions. His primary area of interest is CGlobaltomer and Market Strategy, Market Access, and Digital Health with special focGlobal on emerging markets like Africa, Middle East and APAC. Dr. Purav Gandhi Founder & CEO Anish Swaminathan Director Leadership Team Mukesh is an engineering graduate with an MBA in Marketing. He is a seasoned healthcare market research & marketing professional with a progressive experience of over 20 years in Life Sciences, Pharma and Medical Device sectors. With an in-depth understanding of primary research, he has conducted hundreds of interviews of varioGlobal stakeholders in pharma & healthcare & completed several research projects across life sciences indGlobaltry. Ritu has over 6 years of experience in strategy building, market assessments, market sizing, and RWE for global MNC healthcare & biopharma clients across diff. markets (America, Europe, Africa, APAC and Middle East). Her areas of expertise include: Indentifying emerging trends in life sciences indGlobaltry, Competitor landscape assessment, Disease opportunity assessments etc. She is a pro in secondary and primary research with a deep domain expertise in healthcare sector. Mukesh Nayak Head โ Marketing & Research Ritu Baliya Engagement Manager
- 79.
- 80.
- 81. โฆ and manymore Our Clients
- 82. Web: www.insights10.com Email: [email protected] Call:(+91) 931 639 7935 WhatsApp: (+91) 931 639 7935 We would be happy to help. Do you have any questions?
- 83. www.insights10.com Thank you We trulyappreciate your bGlobaliness and look forward to serving you.